全文获取类型
收费全文 | 6771篇 |
免费 | 556篇 |
国内免费 | 18篇 |
专业分类
耳鼻咽喉 | 68篇 |
儿科学 | 188篇 |
妇产科学 | 157篇 |
基础医学 | 903篇 |
口腔科学 | 66篇 |
临床医学 | 822篇 |
内科学 | 1245篇 |
皮肤病学 | 153篇 |
神经病学 | 843篇 |
特种医学 | 113篇 |
外科学 | 802篇 |
综合类 | 65篇 |
一般理论 | 9篇 |
预防医学 | 732篇 |
眼科学 | 146篇 |
药学 | 520篇 |
中国医学 | 6篇 |
肿瘤学 | 507篇 |
出版年
2024年 | 9篇 |
2023年 | 132篇 |
2022年 | 149篇 |
2021年 | 399篇 |
2020年 | 204篇 |
2019年 | 321篇 |
2018年 | 324篇 |
2017年 | 219篇 |
2016年 | 283篇 |
2015年 | 285篇 |
2014年 | 346篇 |
2013年 | 407篇 |
2012年 | 636篇 |
2011年 | 606篇 |
2010年 | 292篇 |
2009年 | 268篇 |
2008年 | 406篇 |
2007年 | 393篇 |
2006年 | 384篇 |
2005年 | 320篇 |
2004年 | 282篇 |
2003年 | 217篇 |
2002年 | 192篇 |
2001年 | 22篇 |
2000年 | 23篇 |
1999年 | 13篇 |
1998年 | 20篇 |
1997年 | 23篇 |
1996年 | 12篇 |
1995年 | 14篇 |
1994年 | 12篇 |
1993年 | 10篇 |
1992年 | 15篇 |
1991年 | 14篇 |
1990年 | 14篇 |
1989年 | 4篇 |
1988年 | 4篇 |
1987年 | 8篇 |
1986年 | 4篇 |
1985年 | 5篇 |
1984年 | 5篇 |
1983年 | 5篇 |
1982年 | 6篇 |
1981年 | 5篇 |
1980年 | 6篇 |
1977年 | 3篇 |
1975年 | 4篇 |
1974年 | 5篇 |
1964年 | 2篇 |
1963年 | 2篇 |
排序方式: 共有7345条查询结果,搜索用时 390 毫秒
71.
Anna Maria Ierardi Natalie Lucchina Mario Petrillo Chiara Floridi Filippo Piacentino Alessandro Bacuzzi Paolo Fonio Federico Fontana Carlo Fugazzola Luca Brunese Gianpaolo Carrafiello 《La Radiologia medica》2014,119(7):483-498
Unresectable locally advanced pancreatic cancer with or without metastatic disease is associated with a very poor prognosis. Ablation techniques are based on direct application of chemical, thermal, or electrical energy to a tumor, which leads to cellular necrosis. Initial studies about ablation therapies of the pancreas were associated with significant morbidity and mortality, which limited widespread adoption. Modifications to the various applications, in particular combining the techniques with high-quality imaging and intra-operative approach has enabled real-time treatment monitoring and significant improvements in safety. Inoperable cases of pancreatic cancer have been treated by various ablation techniques in the last few years with promising results. The purpose of this review is to present the current status of local ablative therapies in the treatment of pancreatic advanced tumor. 相似文献
72.
73.
Twelve microsatellite markers were developed for the scallop Pecten maximus. The markers were tested in three geographically diverse populations and all markers were polymorphic in all three populations. The mean number of alleles per locus ranged from 2 to 10.67 and the observed and expected heterozygosity ranged from 0.05 to 0.67 and 0.05 to 0.81 respectively. Some loci showed evidence of null alleles and an excess of homozygotes in some populations but 9 loci conformed to Hardy–Weinberg expectations. These new loci can be combined with previously published microsatellites to create a powerful suite of markers for genetic analyses. 相似文献
74.
75.
76.
77.
Efrem S. Lim Natalie M. Meinerz Blake Primi David Wang Robert L. Garcea 《Emerging infectious diseases》2014,20(9):1559-1561
STL polyomavirus (STLPyV) was recently identified in human specimens. To determine seropositivity for STLPyV, we developed an ELISA and screened patient samples from 2 US cities (Denver, Colorado [500]; St. Louis, Missouri [419]). Overall seropositivity was 68%–70%. The age-stratified data suggest that STLPyV infection is widespread and commonly acquired during childhood. 相似文献
78.
Mauro Loi Michael Frelinghuysen Natalie Desiree Klass Esther Oomen-De Hoop Patrick Vincent Granton Joachim Aerts Cornelis Verhoef Joost Nuyttens 《Clinical & experimental metastasis》2018,35(7):625-633
Stereotactic body radiotherapy (SBRT) has emerged as an effective option in oligo-metastatic cancer patients affected by lymph node metastases, but its use might be questioned due to risk of regional and distant dissemination through the lymph node chain. The primary aim of our study was to assess the loco-regional control following SBRT in this setting. Ninety-one patients undergoing SBRT for at least one lymph node metastasis from miscellaneous primary tumors were retrospectively evaluated for patterns of failure and toxicity. locoregional relapse-free survival (LRRFS) and distant metastasis-free survival (DMFS) at 4 years were 79 and 44%. Repeated use of local therapy after progression resulted in a median interval of 17 months until allocation to systemic therapy or supportive care. Forty-three percent of patients were alive at 4 years. Local failure, occurring in 15% of patients, was the only predictor of poor survival (HR: 3.06). Tumor diameter?≥?30 mm and urothelial primary tumor predicted for impaired local control (HR: 4.59 and 5.43, respectively). Metastases from pulmonary cancer showed a significant earlier distant dissemination (HR: 3.53). Only acute and late grade 1–2 toxicities were reported except for 1 case of G3 dysphagia. Loco-regional failure risk is low (18%) and justifies the use of local therapies for patients with oligometastatic disease. Durable disease remission can be achieved by iterative use of local approaches. Local control is correlated to improved OS. Diameter and primary tumor type may affect response to SBRT and risk for early metastatic dissemination. 相似文献
79.
80.